Immediate Impact

2 by Nobel laureates 1 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
2025 Standout
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
2 intermediate papers

Works of Jula K. Inrig being referenced

Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis
2020
The Landscape of Clinical Trials in Nephrology: A Systematic Review of ClinicalTrials.gov
2013

Author Peers

Author Last Decade Papers Cites
Jula K. Inrig 1566 890 644 52 2.5k
Alberto Martínez‐Castelao 1376 408 281 74 2.6k
Ryan D. Kilpatrick 2644 368 792 50 4.0k
Jeffrey S. Berns 1878 244 840 137 4.0k
Carola Grönhagen‐Riska 1446 576 313 120 4.8k
Ashley Irish 795 357 320 114 2.5k
Norman Muirhead 1957 389 526 90 4.6k
Ognjenka Djurdjev 2558 795 582 88 4.5k
Lloyd S. Ibels 1609 203 630 36 2.5k
José Luis Górriz 1390 656 201 183 3.4k
David J. Leehey 1453 984 221 108 3.3k

All Works

Loading papers...

Rankless by CCL
2026